I agree that this site is using cookies. You can find further informations here.
X
Lattuada, E.
342  results:
Search for persons X
?
1

Interpenetrating gels in binary suspensions of DNA nanostar:

Lattuada, E. ; Pietrangeli, T. ; Sciortino, F.
The Journal of Chemical Physics.  157 (2022)  13 - p. , 2022
Link: https://doi.org/10.1063/..
 
?
2

Darunavir/ritonavir 600/100 mg once daily: it's time for la..:

Nicolè, S ; Lanzafame, M ; Cucchetto, G...
Journal of Antimicrobial Chemotherapy.  73 (2018)  6 - p. 1728-1730 , 2018
Link: https://doi.org/10.1093/..
 
?
3

A short course of gluten free diet is effective treatment f..:

Lattuada, E. ; Chiarioni, G. ; Pecori, S...
European Geriatric Medicine.  8 (2017)  4 - p. 346-348 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Lack of Difference between the Reduced Dose and Full-Dose o..:

Nicolè, S ; Cucchetto, G ; Lanzafame, M..
Annals of Antivirals and Antiretrovirals.  1 (2017)  1 - p. 001-003 , 2017
Link: https://doi.org/10.17352..
 
?
5

Dual therapy with a combination of unboosted atazanavir and..:

Rigo, F ; Cucchetto, G ; Lanzafame, M...
HIV Medicine.  18 (2017)  10 - p. 790-792 , 2017
Link: https://doi.org/10.1111/..
 
?
6

Efficacy of a reduced dose of darunavir/ritonavir in a coho..:

Lanzafame, M. ; Lattuada, E. ; Rigo, F....
Journal of Antimicrobial Chemotherapy.  70 (2014)  2 - p. 627-630 , 2014
Link: https://doi.org/10.1093/..
 
?
7

Efavirenz dose reduction in HIV‐infected patients:

Lanzafame, M ; Bonora, S ; Lattuada, E.
HIV Medicine.  13 (2012)  4 - p. 252-253 , 2012
Link: https://doi.org/10.1111/..
 
?
8

Can antiretroviral therapy be safely interrupted and, if so..:

Lattuada, E ; Lanzafame, M ; Vento, S
HIV Medicine.  12 (2010)  2 - p. 126-127 , 2010
Link: https://doi.org/10.1111/..
 
?
9

Prior Mycobacterium avium complex infection is linked to im..:

Lattuada, E ; Vallone, A ; Lanzafame, M...
HIV Medicine.  11 (2010)  8 - p. 542-543 , 2010
Link: https://doi.org/10.1111/..
 
?
10

Raltegravir: is a 400 mg once-daily dose enough?:

Lanzafame, M. ; Hill, A. ; Lattuada, E...
Journal of Antimicrobial Chemotherapy.  65 (2010)  3 - p. 595-597 , 2010
Link: https://doi.org/10.1093/..
 
?
11

Metabolic parameters after BioEnterics Intragastric Balloon..:

Donadio, F. ; Sburlati, L. F. ; Masserini, B....
Journal of Endocrinological Investigation.  32 (2009)  2 - p. 165-168 , 2009
Link: https://doi.org/10.1007/..
 
?
12

Comment on: Unboosted fosamprenavir is associated with low ..:

Lanzafame, M. ; Lattuada, E. ; Corsini, F.
Journal of Antimicrobial Chemotherapy.  64 (2009)  1 - p. 215-216 , 2009
Link: https://doi.org/10.1093/..
 
?
13

Initial Hospitalization and Adherence to Highly Active Anti..:

Lattuada, E. ; Lanzafame, M. ; Gottardi, M....
Clinical Infectious Diseases.  46 (2008)  6 - p. 957-958 , 2008
Link: https://doi.org/10.1086/..
 
?
14

Voluntary or Universal HIV Testing in Italy?:

Vento, S. ; Lanzafame, M. ; Pellegrino, R....
Clinical Infectious Diseases.  46 (2008)  4 - p. 644-645 , 2008
Link: https://doi.org/10.1086/..
 
?
15

Drug Interactions between Warfarin and Efavirenz or Lopinav..:

Bonora, S. ; Lanzafame, M. ; D'Avolio, A....
Clinical Infectious Diseases.  46 (2008)  1 - p. 146-147 , 2008
Link: https://doi.org/10.1086/..
 
1-15